Boston Scientific Corpora...

NYSE: BSX · Real-Time Price · USD
104.16
1.66 (1.62%)
At close: Aug 14, 2025, 3:59 PM
104.45
0.28%
Pre-market: Aug 15, 2025, 04:14 AM EDT

Boston Scientific Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
414M 865M 928M 1.93B
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
555M 413M 407M 412M
Other Long-Term Assets
749M 680M 707M 563M
Receivables
2.56B 2.23B 1.97B 1.78B
Inventory
2.81B 2.48B 1.87B 1.61B
Other Current Assets
831M 622M 731M 799M
Total Current Assets
6.92B 6.51B 5.76B 6.32B
Property-Plant & Equipment
3.74B 3.3B 2.83B 2.69B
Goodwill & Intangibles
23.77B 20.39B 18.82B 18.11B
Total Long-Term Assets
32.48B 28.62B 26.71B 25.91B
Total Assets
39.4B 35.14B 32.47B 32.23B
Account Payables
960M 942M 862M 794M
Deferred Revenue
306M 266M 220M 208M
Short-Term Debt
1.78B 531M 20M 261M
Other Current Liabilities
491M 1.92B 1.64B 629M
Total Current Liabilities
6.4B 4.93B 3.8B 4.27B
Long-Term Debt
8.84B 8.57B 8.91B 8.8B
Other Long-Term Liabilities
1.14B 1.27B 1.4B 1.55B
Total Long-Term Liabilities
10.99B 10.67B 11.09B 11.33B
Total Liabilities
17.39B 15.61B 14.9B 15.61B
Total Debt
11.15B 9.49B 9.28B 9.45B
Common Stock
17M 17M 17M 17M
Retained Earnings
2.67B 819M -750M -1.39B
Comprehensive Income
275M 49M 269M 263M
Shareholders Equity
21.77B 19.28B 17.57B 16.62B
Total Investments
555M 413M 407M 412M